SI
CLVS

Sofinnova Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

Sofinnova Investments’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-125,303
Closed -$1.86M – 87
2019
Q2 		$1.86M Buy
125,303
+58,668
+88% +$1.06M 0.17% 61
2019
Q1 		$1.65M Sell
66,635
-221,134
-77% -$5.54M 0.16% 58
2018
Q4 		$5.17M Buy
+287,769
New +$5.88M 0.64% 32

Other funds holding CLVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Sofinnova Investments's CLVS Position: Q3 2019 in Review

Sofinnova Investments sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 125,303 shares — an estimated $1.86M sold.

Sofinnova Investments first reported a position in CLVS in Q4 2018 and held it in 3 quarters. The position peaked at $5.17M in Q4 2018. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

  • Sofinnova Investments reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
  • Sofinnova Investments sold 125,303 Clovis Oncology, Inc. shares in Q3 2019, an estimated $1.86M.
  • Sofinnova Investments first reported a position in Clovis Oncology, Inc. in Q4 2018 and held it in 3 quarters.
  • Sofinnova Investments's Clovis Oncology, Inc. position peaked at $5.17M in Q4 2018.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Sofinnova Investments's 13F filing for Q3 2019, filed 14 Nov 2019.